Cargando…
Biocapital : The Constitution of Postgenomic Life /
Biocapital is a major theoretical contribution to science studies and political economy. Grounding his analysis in a multi-sited ethnography of genomic research and drug development marketplaces in the United States and India, Kaushik Sunder Rajan argues that contemporary biotechnologies such as gen...
| Autor principal: | |
|---|---|
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Durham :
Duke University Press,
2006.
|
| Colección: | Book collections on Project MUSE.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a22000004a 4500 | ||
|---|---|---|---|
| 001 | musev2_68891 | ||
| 003 | MdBmJHUP | ||
| 005 | 20230905051125.0 | ||
| 006 | m o d | ||
| 007 | cr||||||||nn|n | ||
| 008 | 100809s2006 ncu o 00 0 eng d | ||
| 020 | |a 9780822388005 | ||
| 020 | |z 9780822337089 | ||
| 020 | |z 9780822337201 | ||
| 035 | |a (OCoLC)1139401695 | ||
| 040 | |a MdBmJHUP |c MdBmJHUP | ||
| 100 | 1 | |a Sunder Rajan, Kaushik, |d 1974- | |
| 245 | 1 | 0 | |a Biocapital : |b The Constitution of Postgenomic Life / |c Kaushik Sunder Rajan. |
| 264 | 1 | |a Durham : |b Duke University Press, |c 2006. | |
| 264 | 3 | |a Baltimore, Md. : |b Project MUSE, |c 2020 | |
| 264 | 4 | |c ©2006. | |
| 300 | |a 1 online resource (360 pages). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Introduction : capitalisms and biotechnologies -- Circulations -- Exchange and value : contradictions in market logic in American and Indian genome enterprises -- Life and debt : global and local political ecologies of biocapital -- Articulations -- Vision and hype : the conjuration of promissory biocapitalist futures -- Promise and fetish : genomic facts and personalized medicine, or life is a business plan -- Salvation and nation : underlying belief structures of biocapital -- Entrepreneurs and start-ups : the story of an e-learning company -- Coda : surplus and symptom. | |
| 520 | |a Biocapital is a major theoretical contribution to science studies and political economy. Grounding his analysis in a multi-sited ethnography of genomic research and drug development marketplaces in the United States and India, Kaushik Sunder Rajan argues that contemporary biotechnologies such as genomics can only be understood in relation to the economic markets within which they emerge. Sunder Rajan conducted fieldwork in biotechnology labs and in small start-up companies in the United States (mostly in the San Francisco Bay area) and India (mainly in New Delhi, Hyderabad, and Bombay) over a five-year period spanning 1999 to 2004. He draws on his research with scientists, entrepreneurs, venture capitalists, and policymakers to compare drug development in the two countries, examining the practices and goals of research, the financing mechanisms, the relevant government regulations, and the hype and marketing surrounding promising new technologies. In the process, he illuminates the global flow of ideas, information, capital, and people connected to biotech initiatives. Sunder Rajan's ethnography informs his theoretically sophisticated inquiry into how the contemporary world is shaped by the marriage of biotechnology and market forces, by what he calls technoscientific capitalism. | ||
| 546 | |a English. | ||
| 588 | |a Description based on print version record. | ||
| 650 | 7 | |a Läkemedelsindustri. |2 sao | |
| 650 | 7 | |a Genomik |x ekonomiska aspekter. |2 sao | |
| 650 | 7 | |a Bioteknikindustri. |2 sao | |
| 650 | 7 | |a Kommerzialisierung |2 gnd | |
| 650 | 7 | |a Biotechnologische Industrie |2 gnd | |
| 650 | 7 | |a Biotechnologie |2 gnd | |
| 650 | 7 | |a Marktwirtschaft |2 gnd | |
| 650 | 7 | |a Kapitalismus |2 gnd | |
| 650 | 7 | |a Pharmaceutical industry. |2 fast |0 (OCoLC)fst01060129 | |
| 650 | 7 | |a Biotechnology industries. |2 fast |0 (OCoLC)fst00832791 | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x General. |2 bisacsh | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x Pharmaceutical & Biotechnology. |2 bisacsh | |
| 650 | 6 | |a Medecine |x Histoire |y 21e siecle. | |
| 650 | 6 | |a Medecine |x Histoire |y 20e siecle. | |
| 650 | 6 | |a Industrie pharmaceutique. | |
| 650 | 6 | |a Genomique |x Aspect economique. | |
| 650 | 6 | |a Bio-industries. | |
| 650 | 2 | |a Drug Industry | |
| 650 | 2 | 2 | |a History, 21st Century |
| 650 | 2 | 2 | |a History, 20th Century |
| 650 | 2 | 2 | |a Drug Industry |x history |
| 650 | 2 | 2 | |a Biotechnology |x history |
| 650 | 1 | 2 | |a Genomics |x history |
| 650 | 1 | 2 | |a Genomics |x economics |
| 650 | 0 | |a Pharmaceutical industry. | |
| 650 | 0 | |a Genomics |x Economic aspects. | |
| 650 | 0 | |a Biotechnology industries. | |
| 655 | 7 | |a Electronic books. |2 local | |
| 710 | 2 | |a Project Muse. |e distributor | |
| 830 | 0 | |a Book collections on Project MUSE. | |
| 856 | 4 | 0 | |z Texto completo |u https://projectmuse.uam.elogim.com/book/68891/ |
| 945 | |a Project MUSE - Custom Collection | ||